PharmaCyte Biotech (PMCB) Prepaid Assets (2011 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Prepaid Assets of $96879.0 for Q2 2026, down 56.7% year-over-year from $223759.0 in Q2 2025, and down 38.94% quarter-over-quarter from $158664.0 in Q1 2026.
PharmaCyte Biotech (PMCB) Prepaid Assets (2011 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Prepaid Assets for 16 consecutive years, with $96879.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Prepaid Assets fell 56.7% year-over-year to $96879.0; the TTM figure through Apr 2026 stood at $96879.0 (down 56.7% YoY), while the FY2026 annual figure was $96879.0, down 56.7% from the prior year.
- Prepaid Assets eased to $96879.0 in Q2 2026 per PMCB's latest filing, from $158664.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $503147.0 in Q4 2025 and bottomed at $28148.0 in Q3 2022.
- Historically, Prepaid Assets has averaged $220708.3 across 5 years, with a median of $215560.5 in 2025.
- On a YoY basis, Prepaid Assets climbed as much as 317.41% in 2022 and fell as far as 94.87% in 2022.
- PharmaCyte Biotech's Prepaid Assets stood at $256808.0 in 2022, then climbed by 25.85% to $323189.0 in 2023, then soared by 52.61% to $493213.0 in 2024, then climbed by 2.01% to $503147.0 in 2025, then sank by 80.75% to $96879.0 in 2026.
- Business Quant data shows PMCB's Prepaid Assets at $96879.0 in Q2 2026, $158664.0 in Q1 2026, and $503147.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 96,879.00 |
| Jan 31, 2026 | 158,664.00 |
| Oct 31, 2025 | 503,147.00 |
| Jul 31, 2025 | 238,180.00 |
| Apr 30, 2025 | 223,759.00 |
| Jan 31, 2025 | 207,362.00 |
| Oct 31, 2024 | 493,213.00 |
| Jul 31, 2024 | 240,227.00 |
| Apr 30, 2024 | 259,800.00 |
| Jan 31, 2024 | 297,762.00 |
| Oct 31, 2023 | 323,189.00 |
| Jul 31, 2023 | 88,650.00 |
| Apr 30, 2023 | 107,681.00 |
| Jan 31, 2023 | 181,008.00 |
| Oct 31, 2022 | 256,808.00 |
| Jul 31, 2022 | 28,148.00 |
| Apr 30, 2022 | 94,172.00 |
| Jan 31, 2022 | 174,101.00 |
| Oct 31, 2021 | 241,799.00 |
| Jul 31, 2021 | 549,094.00 |